CClinicalTrials.gg
CompletedNCT07033936Updated Jul 8, 2025

Prevalence of Irritable Bowel Syndrome Among Egyptian Medical Students

An observational study in Irritable Bowel Syndrome, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 18 Years to 27 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by Zagazig University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
1,093
Ages
18 Years to 27 Years
Sex
All
01

Study summary

Assess prevalence of irritable bowel syndrome among both medical students and medical interns, and the most significant risk factors of this condition, and highlight the association between IBS symptoms, anxiety \& depression.

Read the detailed description

One of the most common gastrointestinal disorders is irritable bowel syndrome (IBS). It is a chronic functional bowel disease in which abnormal bowel habits, such as diarrhea, constipation, or both, are associated with abdominal pain and distension. Around 11% of the general population suffers from their symptoms regardless of the geographical distribution.

Irritable bowel syndrome is more common among females and patients younger than 50. For medical students, IBS is common and may affect up to 25% of them.. Especially final-year students, due to the increasing workload of the final year.

Several risk factors increase the prevalence of irritable bowel syndrome, including environmental factors, life events, and junk food abuse. Also, Psychological disorders as severe levels of anxiety, depression, and stress, may contribute to the occurrence of irritable bowel syndrome, and this can be explained by the pathophysiology of IBS, maybe by brain-gut interaction.

Globally, the prevalence of anxiety and depression is higher in medical students compared to other populations, as it reaches up to 38.7% among them. Many factors play a role in increasing the prevalence of anxiety and depression among medical students as stressful courses in medical study, exposure to the death of patients, and others. In Egypt, the prevalence of medical students suffering from stress and anxiety is high due to several problems as financial problems, work overload, traditional methods of education, and the increasing number of students, making communication with thePage 3 of 9 lecturer difficult and that increase incidence of IBS among Egyptian medical students.

Just as anxiety is considered a risk factor for the development of Irritable Bowel Syndrome (IBS), IBS can also lead to the occurrence of anxiety and depression, and that can be explained by brain-gut interaction.

Patients with IBS have a three-times increased risk of either anxiety or depression, compared to healthy subjects.

Although the importance of this topic is recognized, there are limited data about the exact prevalence of irritable bowel syndrome among medical students in Egypt.

Previous studies have discussed this topic in three medical schools in Egypt, but their sample size were too small, and they did not assess the associated anxiety and depression among these students, so no definitive conclusion can be made. This is the first study in Zagazig University hospital to assess the prevalence of irritable bowel syndrome among both medical students and medical interns, and the most significant risk factors of this condition, and highlight the association between IBS symptoms and anxiety and depression.

02

Conditions studied

  • Irritable Bowel Syndrome
03

In context

Irritable Bowel Syndrome

1,062 studies on the registry are indexed under Irritable Bowel Syndrome; 190 are open to participants now.

This study's enrollment of 1,093 is above the median of 150 across 178 observational studies indexed under Irritable Bowel Syndrome.

Browse Irritable Bowel Syndrome studies →

Lead sponsor

Zagazig University is the lead sponsor of 447 studies on the registry; 75 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 27 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Egyptian Medical students and Intern

Inclusion criteria

  • Egyptian Medical students and interns
  • Their age ranges from 18 to 29 years
  • Have access to online platforms such as Facebook, WhatsApp, and Telegram.
  • Accept to participate in the questionnaire

Exclusion criteria

Exclusion Criteria:

  • Participate who refused to participate
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
1,093 participants (actual)
Patient registry
No

Interventions

  • OtherQuestionnaire

    An online Questionnaire will be shared via social media such as WhatsApp, Facebook or X for Egyptian medical students and intern to fill

06

What researchers measure

Primary outcomes

  1. Number of irritable bowel syndrome patients among population

    Will use Rome IV criteria to diagnose IBS. It is composed of three questions about the presence of GIT symptoms. The presence of at least two of the three diagnoses the IBS.

    Time frame: 1 month

Secondary outcomes

  1. Number of IBS patients suffering anxiety and depression

    Will use the HAD questionnaire to diagnose both anxiety and depression. It is a 14 questionnaire divided into two subscales, one for anxiety and the other for depression. Each question is composed of 4 answers, scored from 0 to 3. Cumulative score for each subscale determines the level of either anxiety or depression. an individual can score between 0 and 21 for either anxiety or depression, and be classified into the following categories: 0 to 7, normal; 8 to 10, borderline; and 11 to 21, abnormal (case)

    Time frame: 1 month

07

Study locations

1 site
  • Zagazig University Faculty of Medicine and Affiliated Hospital
    Zagazig, Egypt
08

References and documents

Publications

  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x. PubMed 6880820 ↗

Study documents

  • Study protocol · Jun 3, 2025

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07033936
Lead sponsor
Zagazig University
Responsible party
Sponsor
First posted
Jun 24, 2025
Start date
Jun 10, 2025
Primary completion
Jun 30, 2025
Completion
Jul 6, 2025
Last update
Jul 8, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion